These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19501510)

  • 21. GETAWAY descriptors to predicting A(2A) adenosine receptors agonists.
    González MP; Terán C; Teijeira M; González-Moa MJ
    Eur J Med Chem; 2005 Nov; 40(11):1080-6. PubMed ID: 16006015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
    Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions.
    Trevethick MA; Mantell SJ; Stuart EF; Barnard A; Wright KN; Yeadon M
    Br J Pharmacol; 2008 Oct; 155(4):463-74. PubMed ID: 18846036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease.
    D'Alimonte I; D'Auro M; Citraro R; Biagioni F; Jiang S; Nargi E; Buccella S; Di Iorio P; Giuliani P; Ballerini P; Caciagli F; Russo E; De Sarro G; Ciccarelli R
    Eur J Neurosci; 2009 Sep; 30(6):1023-35. PubMed ID: 19723291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
    Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
    Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA
    Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 3: Synthesis and activity of isosteric analogs.
    Kai H; Morioka Y; Koriyama Y; Okamoto K; Hasegawa Y; Hattori M; Koike K; Chiba H; Shinohara S; Iwamoto Y; Takahashi K; Tanimoto N
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6444-7. PubMed ID: 18977140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel H3 receptor antagonists with improved pharmacokinetic profiles.
    Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Semple G; Ren A; Pereira G; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Lorea J; Grottick AJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4133-6. PubMed ID: 18554904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
    El-Tayeb A; Iqbal J; Behrenswerth A; Romio M; Schneider M; Zimmermann H; Schrader J; Müller CE
    J Med Chem; 2009 Dec; 52(23):7669-77. PubMed ID: 19580286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory activity of prostaglandin E2 production by the synthetic 2'-hydroxychalcone analogues: Synthesis and SAR study.
    Tran TD; Park H; Kim HP; Ecker GF; Thai KM
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1650-3. PubMed ID: 19233646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.
    Kuduk SD; DiPardo RM; Chang RK; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3608-12. PubMed ID: 17482459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
    Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and application of locally delivered agonists of the adenosine A(2A) receptor.
    Mantell S; Jones R; Trevethick M
    Expert Rev Clin Pharmacol; 2010 Jan; 3(1):55-72. PubMed ID: 22111533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists.
    Shao Y; Cole AG; Brescia MR; Qin LY; Duo J; Stauffer TM; Rokosz LL; McGuinness BF; Henderson I
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1399-402. PubMed ID: 19181527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.